Your Location:
Home >
Browse articles >
Reversing effects of interferon α on drug resistance of bone marrow cells in leukemia
Updated:2026-03-12
    • Reversing effects of interferon α on drug resistance of bone marrow cells in leukemia

    • Military Medical Research Vol. 0, Issue 4, Pages: 286-288(1999)

    Scan QR Code

  •  
  •  
  • Full Text(HTML)

  • Publication Info

  • Metrics

Sections
icon
The trial reading is over, you can activate your VIP account to continue reading.
Deactivate >
icon
The trial reading is over. You can log in to your account, go to the personal center, purchase VIP membership, and read the full text.
Already a VIP member?
Log in >

5

Views

3

Downloads

0

CSCD

Alert me when the article has been cited
Submit
Tools
  • BibTeXDownload
  • EndnoteDownload
  • RefMan Download
  • NoteExpressDownload
  • NoteFirstDownload

Related Articles

Expression dynamics of periodic transcripts during cancer cell cycle progression and their correlation with anticancer drug sensitivity
An integrated microfluidics platform with high-throughput single-cell cloning array and concentration gradient generator for efficient cancer drug effect screening
The correlation between clonal evolution and recurrent acute leukemia:A report of 2 cases
From RCT to mechanistic study: ATRA reverses myofibroblast activation by reprogramming glucose metabolism via HIC1 and PCK1/2 to attenuate hypertrophic scar formation
Octopus-inspired engineered bacteria with a plug-and-play surface display system achieves enhanced tumor-specific colonization and antitumor immunity

Related Author

Hai-Li Qian
Chun-Xiao Li
Jin-Song Wang
Wen-Na Wang
Dong-Kui Xu
Yan-Tong Zhou
Fang-Zhou Sun
Yi-Qun Li

Related Institution

Department of VIP, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
State Key Laboratory of Molecular Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
Canary Center at Stanford for Cancer Early Detection, Department of Radiology, School of Medicine, Stanford University
University of Chinese Academy of Sciences